Underestimates of Intussusception Rates among US Infants Based on Inpatient Discharge Data: Implications for Monitoring the Safety of Rotavirus Vaccines

Cortese, Margaret M.; Staat, Mary Allen; Weinberg, Geoffrey A.; Edwards, Kathryn; Rice, Marilyn A.; Szilagyi, Peter G.; Hall, Caroline B.; Payne, Daniel C.; Parashar, Umesh D.
November 2009
Journal of Infectious Diseases;11/2/2009, Vol. 200 Issue S1, pS264
Academic Journal
Background. Because a previous rotavirus vaccine was associated with intussusception, new rotavirus vaccines are monitored postlicensure for any such association. Accurate background intussusception rates are needed to determine whether the number of cases observed after vaccination exceeds that expected by chance. Previously, intussusception rates were obtained from inpatient discharge databases. We sought to determine the rate of intussusception among infants managed only with short-stay or emergency department care. Methods. Intussusception cases occurring in infants were identified retrospectively at 3 children's hospitals from January 2001 through March 2006, a period without rotavirus vaccine use, by a search of discharge, billing, and radiology databases for International Classification of Diseases, Ninth Revision, Clinical Modification code 560.0 (intussusception) and procedure codes and by review of medical records. Results. Of 156 infants with intussusception fulfilling Brighton level 1 criteria, 81 (52%) were billed as inpatients, 68 (44%) as short-stay patients, and 7 (4%) as emergency department patients only. The use of only inpatients assigned code 560.0 underestimated the total number of level 1 cases at the hospitals by 44%. The mean annual intussusception rate for the hospitals' catchment counties was 49.3 cases per 100,000 live births (inpatient cases: 27.1 cases per 100,000 live births; short-stay or emergency department cases: 22.3 cases per 100,000 live births). Conclusions. Intussusception rates based solely on inpatient discharge databases could underestimate the true incidence of level 1 intussusception by >40%. Background rates used for assessment of risk after vaccination should account for cases managed only with short-stay or emergency department care.


Related Articles

  • Intussusception monitoring continues with new rotavirus vaccine.  // Infectious Diseases in Children;Jul2008, Vol. 21 Issue 7, p37 

    The article discusses research being done on intussusception and rotavirus vaccine. It references a study by J. E. Tate et al, published in a 2008 issue of "Pediatrics." The study investigated intussusception hospitalization trends between 1993 and 2004. Researchers also examined hospital...

  • Rotavirus Vaccine (RotaTeq®). Keating, Gillian M. // Pediatric Drugs;2006, Vol. 8 Issue 3, p197 

    ▴ RotaTeq® is a live, oral, pentavalent human-bovine reassortant rotavirus vaccine approved for use in the prevention of G1-G4 rotavirus gastroenteritis in infants and children. ▴ Rotavirus vaccine demonstrated good immunogenicity in healthy infants. ▴ Three oral doses of...

  • Update on intussusception. Orenstein, Julian // Contemporary Pediatrics;Mar2000, Vol. 17 Issue 3, p180 

    Provides information on the occurrence of intussusception among children. Treatment for the condition; Information on its pathophysiology; Relationship with rotavirus vaccination.

  • Rotavirus vaccines: risk of intussusception low.  // Reactions Weekly;Mar2014, Vol. 1490 Issue 1, p3 

    The article presents information on the finding of a study, published in "The New England Journal of Medicine" that assessed the association between intussusception and the two second-generation rotavirus vaccines and the monovalent vaccine among U.S. infants aged between 5 and 37 weeks.

  • A rotavirus vaccine for infants prevented rotavirus gastroenteritis with no increase in risk of intussusception. Heaton, P. // Archives of Disease in Childhood -- Education & Practice Edition;Feb2007, Vol. 92 Issue 1, p32 

    The article discusses research being done on the safety and efficacy of a rotavirus vaccine for infants. It references a study by T. Vesikari et al in the 2006 issue of "New England Journal of Medicine." Vaccination reduced cases of rotavirus gastroenteritis requiring hospital admission or...

  • Rotavirus vaccine withdrawn from the market.  // Child Health Alert;Dec99, Vol. 17, p3 

    Focuses on the withdrawal of the Rotavirus vaccine from the market in the United States. Suspension on the distribution of Rotashield; Recommendation of vaccines by the federal government; Risk factors of intussusception.

  • Rotavirus W179-9 vaccine.  // Reactions Weekly;7/13/2013, Issue 1461, p33 

    An abstract of the article "Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012," by P. Haber and colleagues is presented.

  • Rotavirus vaccine: much benefit, little risk in Mexico and Brazil.  // Archives of Disease in Childhood;Sep2011, Vol. 96 Issue 9, p831 

    The article discusses the result of a study conducted in Mexico and Brazil on the risk of intussusception through the use of the rotavirus vaccine Rotarix (RV1). It shows that there is a small incidence of intussusception in both countries since it is outweighed by the benefits of the...

  • Thumbs up for rotavirus vaccination in China.  // PharmacoEconomics & Outcomes News;7/21/2012, Issue 658, p10 

    The article discusses research on the projected health impact and cost effectiveness of rotavirus vaccination among children below 5 years old in China, referencing a study by N. Liu and colleagues published in the June 14, 2012 issue of "Vaccine."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics